Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Fibromyalgia pain is real. And so is treatment with Lyrica

Lyrica is the first treatment indicated in Canada for the management of pain associated with fibromyalgia in adults.

Brand name: Lyrica
Generic name/category: Pregabalin, Anticonvulsant
Company: Pfizer
Country/Market: Canada, North America
Indication(s)/use: Fibromyalgia, pain management
Target: Healthcare Professionals (HCP)
Tagline: Fibromyalgia pain is real. And so is treatment with Lyrica
Medium: Print ad
Size/duration: single-page
Publication/Aired: New England Journal of Medicine (NEJM) – August 27, 2009

To see all of this brand’s ads on AdPharm, click here

More Dulcolax ads on AdPharm

New indication
Fibromyalgia pain is real. And so is treatment with Lyrica.
Lyrica is the first treatment indicated in Canada for the management of pain associated with fibromyalgia in adults.

Pregabalin (INN) is an anticonvulsant drug used for neuropathic pain and as an adjunct therapy for partial seizures with or without secondary generalization in adults. It has also been found effective for generalized anxiety disorder and is (as of 2007) approved for this use in Europe. It was designed as a more potent successor to gabapentin. Pregabalin is marketed by Pfizer under the trade name Lyrica.

Recent studies have shown that pregabalin is effective at treating chronic pain in disorders such as fibromyalgia and spinal cord injury. In June 2007, pregabalin became the first medication approved by the U.S. Food and Drug Administration specifically for the treatment of fibromyalgia.

It is considered to have a low potential for abuse, and a limited dependence liability if misused, and is thus classified as a Schedule V drug in the U.S.

More on Wikipedia

Journal of Psychiatry and Neuroscience May 2009